Stay updated on Prevent Early Onset AD Clinical Trial
Sign up to get notified when there's something new on the Prevent Early Onset AD Clinical Trial page.

Latest updates to the Prevent Early Onset AD Clinical Trial page
- Check5 days agoChange DetectedThe page now displays Revision: v3.0.2, replacing v3.0.1. The 'Back to Top' link was removed.SummaryDifference0.1%
- Check12 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.1%
- Check20 days agoChange DetectedThe web page has been updated to include new facility names and locations, as well as additional drug information related to Alzheimer's treatments, including Lecanemab and gantenerumab. Some previous MedlinePlus topics and location details have been removed.SummaryDifference13%
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.0%
- Check41 days agoChange DetectedThe page has been updated to reflect the latest version as v2.16.11, replacing the previous version v2.16.10. The phrasing regarding the last update has also changed from 'Estimated' to a definitive statement.SummaryDifference0.1%
- Check48 days agoChange DetectedThe webpage has updated its personnel listings, adding new names such as Edward Huey, Emma Devenney, and David Aguillón, M.D., while removing previous names like Ghulam Surti and Francisco Lopera, M.D. Additionally, the last update date has been revised to reflect more recent information.SummaryDifference1%
Stay in the know with updates to Prevent Early Onset AD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Prevent Early Onset AD Clinical Trial page.